Labviva co-founders Nicholas Rioux, chief technology officer (L) and CEO Siamak Baharloo
March 27, 2023 08:00 AM EDT
Financing
Startups
Manufacturing

Lab­vi­va nets $20M Se­ries A to ease life sci­ence pro­cure­ment process

Tyler Patchen

News Reporter

Or­der­ing and procur­ing sup­plies and ma­te­ri­als for re­searchers and pro­duc­ers in the life sci­ences in­dus­try is an im­por­tant step, but it can be a com­plex …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Dai­ichi Sankyo finds suc­ces­sor to late R&D ex­ec; Ver­sant, No­var­tis' kid­ney biotech poach­es Sana CBO

A service from the Financial Times